Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ERAS
ERAS logo

ERAS News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

ERAS News

ImmunityBio's Anktiva Receives EU Approval, Boosting Stock

13h agostocktwits

Erasca CMO Sells Shares Under 10b5-1 Plan

5d agoNASDAQ.COM

Erasca CMO Sells Shares in SEC Filing

5d agoFool

Erasca Reports Q4 2025 Financial Results with Reduced Losses

Mar 12 2026seekingalpha

Wall Street Analysts Adjust Ratings

Mar 06 2026Benzinga

Tango Therapeutics Shares Surge 24% to New 52-Week High Following Collaboration with Erasca

Mar 05 2026seekingalpha

Erasca Partners with Tango for Clinical Trial of ERAS-0015

Mar 05 2026Newsfilter

FDA's Accelerated Approval Framework Drives Cancer Treatment Advances

Feb 17 2026Newsfilter

ERAS Events

No data

No data

ERAS Monitor News

Erasca Inc. Closes $258.8 Million Upsized Public Offering

Jan 26 2026

Erasca's General Counsel Sells Shares Amid Market Confidence

Jan 15 2026

Erasca Inc Surpasses Analyst Target Price, Stock Rises

Jan 09 2026

Erasca Inc Surges After Analyst Upgrade

Jan 07 2026

ERAS Earnings Analysis

No Data

No Data

People Also Watch